fowlpox-NY-ESO-1 vaccine
Term · Oncology and biomedicine · MLC-T-ONC-013772
A cancer vaccine consisting of a recombinant fowlpox virus vector encoding an immunogenic peptide derived from the cancer-testis antigen NY-ESO-1, an antigen found in normal testis and various tumors, including bladder, breast, hepatocellular, melanoma, and prostate cancers. Vaccination with NY-ESO-1 peptide vaccine may stimulate the host immune system to mount a humoral and cytotoxic T lymphocyte (CTL) response against tumor cells expressing NY-ESO-1 antigen, resulting in tumor cell lysis.
| Identifier | MLC-T-ONC-013772 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | rF-NY-ESO-1 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-013772",
"term": "fowlpox-NY-ESO-1 vaccine",
"field": "Oncology and biomedicine",
"definition": "A cancer vaccine consisting of a recombinant fowlpox virus vector encoding an immunogenic peptide derived from the cancer-testis antigen NY-ESO-1, an antigen found in normal testis and various tumors, including bladder, breast, hepatocellular, melanoma, and prostate cancers. Vaccination with NY-ESO-1 peptide vaccine may stimulate the host immune system to mount a humoral and cytotoxic T lymphocyte (CTL) response against tumor cells expressing NY-ESO-1 antigen, resulting in tumor cell lysis.",
"abbreviation": "rF-NY-ESO-1",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/fowlpox-ny-eso-1-vaccine/"
}
Record 7,598 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.